Successful Treatment of Lupus Anticoagulant-Hypoprothrombinemia Syndrome Using Intravenous Immunoglobulins

1997 ◽  
Vol 78 (02) ◽  
pp. 969-970 ◽  
Author(s):  
Gilles Pernod ◽  
Josiane Arvieux ◽  
Patrick H Carpentier ◽  
Pascal Mossuz ◽  
Jean Luc Bosson ◽  
...  
2019 ◽  
Vol 12 (3) ◽  
pp. e224636
Author(s):  
Ziyang Liu ◽  
Merry Markham ◽  
Molly W Mandernach

A 46-year-old man presented with splenomegaly, abdominal adenopathy and profoundly elevated prothrombin time and partial thromboplastin time. He was diagnosed with marginal zone lymphoma (MZL) and small lymphocytic lymphoma, and the abnormal coagulation studies were secondary to the presence of a lupus anticoagulant. Optimal upfront therapy for MZL has not been established, and the incidence of antiphospholipid antibodies (APLA) in this patient population is rare. Following treatment with six cycles of bendamustine and rituximab with 2 years of rituximab maintenance, our patient remained in remission and his coagulation studies normalised. This report describes a case of successful treatment of APLA associated with MZL that resolved after treatment of the lymphoma.


2008 ◽  
Vol 83 (2) ◽  
pp. 159-162 ◽  
Author(s):  
Arnaud Hot ◽  
Marie Hélène Girard Madoux ◽  
Jean P. Viard ◽  
Brigitte Coppéré ◽  
Jacques Ninet

2000 ◽  
Vol 65 (1) ◽  
pp. 74-76 ◽  
Author(s):  
Claire Larroche ◽  
Luc Mouthon ◽  
Nicole Casadevall ◽  
Geneviève Le Roux ◽  
Philippe Casassus ◽  
...  

1999 ◽  
Vol 18 (1) ◽  
pp. 77-81 ◽  
Author(s):  
H. Arahata ◽  
K. Migita ◽  
H. Izumoto ◽  
T. Miyashita ◽  
H. Munakata ◽  
...  

2012 ◽  
Vol 148 (10) ◽  
pp. 1126 ◽  
Author(s):  
Maximilian C. Aichelburg ◽  
Robert Loewe ◽  
Nikolaus Schicher ◽  
Paul-Gunther Sator ◽  
Franz M. Karlhofer ◽  
...  

2006 ◽  
Vol 132 (5) ◽  
pp. 824-826 ◽  
Author(s):  
C. MOHR ◽  
C. SUNDERKÖTTER ◽  
A. HILDEBRAND ◽  
K. BIEL ◽  
A. RÜTTER ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document